USE OF AMOXICILLIN/CLAVULANIC ACID IN UPPER RESPIRATORY TRACT INFECTIONS
- Authors: Kolosova K.Y.1, Kolosova KY.1
-
Affiliations:
- Issue: No 5 (2012)
- Pages: 39-44
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279418
- ID: 279418
Cite item
Full Text
Abstract
Upper respiratory tract infections caused by bacterial pathogens are common in clinical practice. In recent decades, there is steady growth of pathogen resistance to traditional antibiotics. The article reviews current recommendations for antibiotic treatment of acute bacterial rhinosinusitis and tonsillopharyngitis in adult patients.
References
- Синопальников А.И., Козлов Р.С. Внебольничные инфекции дыхательных путей. Руководство для врачей. М., 2007. 352 с.
- Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(1):1-45.
- Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Sinus and Allergy Health Partnership. Otolaryngol Head Neck Surg 2000;123(1 Pt 2):5-31.
- Tewfik TL, Al Garni M. Tonsillopharyngitis: clinical highlights. J Otolaryngol 2005;34(1):S45-49.
- McCaig LF, Hughes LM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273(3):214-19.
- Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52(2):229-46.
- Chambers HF. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. J Infect Dis 1999;179(2):S353-59.
- Bush K. Beta-lactamase inhibitors from laboratory to clinic. Clin Microbiol Rev 1988;1(1):109-23.
- Medeiros AA. Evolution and dissimination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997;24(1):S19-45.
- Hakenbeck R, Kaminski K, Konig A, et al. Penicilli-binding proteins in beta-lactam-resistant streptococcus pneumoniae. Microb Drug Resist 1999;5(2):91-99.
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice an men. Clin Infect Dis 1998;26(1):1-10.
- Jacobs MR. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am J Med 1999;106(5A):19S-25S.
- Appelbaum PC. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 2002;34(12):1613-62.
- File TM, Benninger MS, Jacobs MR. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumoniae in response to antimicrobial-resistance patterns. Clin Lab Med 2004;24:531-51.
- Ahuovo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cohrane Database Syst Rev 2008;(2):CD000243.
- Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, et al. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ 2008;178(7):845-54.
- File TM, Benninger MS, Jacobs MR. Evolution of amoxicillin / clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns. Clin Lab Med 2004(24):531-51.
- Syrogiannopoulos GA, Bozdogan B, Grivea IN, et al. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2004;23(9):857-65.
- Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med 1995;25(3):390-403.
- Крюков А.И., Лучшева Ю.В. Ангина и хронический тонзиллит: проблема выбора антибактериального препарата в амбулаторных условиях // Справочник поликлинического врача 2007. № 5 (4). С. 42-44.
- Poole MD, Portugal LG. Treatment of rhinosinusitis in the outpatient setting. Am J Med 2005;118(7A):45S-50S.
Supplementary files
